NIH-funded research R21 grant

Investigating how diabetes affects brain protein changes in Alzheimer's disease

Official title: Rates of brain acetylome remodeling in a mouse model of diabetes and tauopathy

Funded at Northeast Ohio Medical University · NIH-10807604 · Data updated 2026-11-12

This study is looking at how diabetes might affect the brain and contribute to Alzheimer's disease by checking how certain proteins change in the brain, especially those linked to memory, using mice to help find new ways to treat Alzheimer's.

More Diabetes research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNortheast Ohio Medical University
NIH-funded
Lab location1 site (Rootstown, United States)
Project startSeptember 30, 2023
Project endSeptember 29, 2025
Funding year2023
Award (this year)$429,000
NIH project number1R21AG085590-01
Project IDNIH-10807604 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults with a diagnosis of Alzheimer's disease, especially those who also have type 2 diabetes.

Less likely to help

Patients without Alzheimer's disease or those who do not have diabetes may not benefit from this research.

What this research studies

This research explores the connection between diabetes and Alzheimer's disease by examining how a specific process called acetylation affects brain proteins. Using a mouse model, researchers will analyze changes in protein dynamics in the brain, particularly focusing on areas associated with memory and cognitive function. The study employs advanced mass spectrometry techniques to measure how diabetes influences protein stability and turnover in the context of Alzheimer's. By understanding these mechanisms, the research aims to shed light on potential therapeutic targets for Alzheimer's disease.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for Alzheimer's disease, particularly for patients with diabetes.

How similar studies have gone: While the specific approach of this research is novel, previous studies have shown promising results in understanding the links between metabolic disorders and neurodegenerative diseases.

Where this research is happening

  • Northeast Ohio Medical University
    Rootstown, United States
    Active

Researchers

  • Principal investigator: Kasumov, Takhar — Northeast Ohio Medical University
  • Study coordinator: Kasumov, Takhar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.